SCHEMBL1062902

SCHEMBL1062902

COc1cc(CNCc2ccc(/C=C\C(=O)Nc3ccccc3[N+](=O)[O-])cc2)cc(OC)c1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 9/20 0.59
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
MAPT P10636 4/20 0.53
HDAC3 O15379 4/20 0.53
HDAC2 Q92769 4/20 0.53
HDAC8 Q9BY41 4/20 0.53
ALDH1A1 P00352 3/20 0.51
LMNA P02545 2/20 0.51
KDM4E B2RXH2 1/20 0.51
GAA P10253 1/20 0.51
HPGD P15428 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
TRPV1 Q8NER1 1/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
CYP2C19 P33261 1/20 0.51
POLB P06746 1/20 0.50
ATM Q13315 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2734354 1.00 HDAC1 (0.59) HDAC1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL1062904 1.00 HDAC1 (0.59) HDAC1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL8352293 0.95 HDAC1 (0.54) HDAC1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3630366 0.88 HDAC1 (0.51) HDAC1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL1060486 0.87 HDAC1 (0.60) HDAC1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL1060488 0.87 HDAC1 (0.60) HDAC1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3630368 0.86 HDAC1 (0.54) HDAC1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL1065131 0.85 HDAC1 (0.80) HDAC1HDAC3HDAC2HDAC8HDAC4
SCHEMBL1065134 0.85 HDAC1 (0.80) HDAC1HDAC3HDAC2HDAC8HDAC4
SCHEMBL2732582 0.85 HDAC1 (0.80) HDAC1HDAC3HDAC2HDAC8HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868204-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2011-01-11 US disclosed
US-7838520-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2010-11-23 US disclosed
US-7595343-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2009-09-29 US disclosed
US-20060058298-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2006-03-16 US disclosed
US-20050288282-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2005-12-29 US disclosed
US-6897220-B2 Inhibitors of histone deacetylase METHYLGENE, INC. (CA) 2005-05-24 US disclosed
US-20040142953-A1 Inhibitors of histone deacetylase METHYLGENE, INC. 2004-07-22 US disclosed
US-20040106599-A1 Inhibitors of histone deacetylase 92229129 QUEBEC INC. (CA) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288282-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 HDAC1 1/4885NPC1 1197/4885RAB9A 2909/4885
US-20040106599-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 HDAC1 1/4885NPC1 1197/4885RAB9A 2909/4885
US-20060058298-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 HDAC1 1/4885NPC1 1197/4885RAB9A 2909/4885
US-20040142953-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 HDAC1 1/4885NPC1 1197/4885RAB9A 2909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.